Peter Halfmann is an assistant professor at the Influenza Research Institute, within the Department of Pathobiological Sciences at the School of Veterinary Medicine, University of Wisconsin-Madison.
Dr. Halfmann’s research is dedicated to understanding emerging and re-emerging viruses, including filoviruses, coronaviruses, and influenza viruses. His work focuses on elucidating the mechanisms of pathogenicity and transmission, as well as identifying viral and host determinants that contribute to the pandemic or outbreak potential of these viruses. As a visiting scientist at NIAID’s high containment biosafety level-4 facility at Rocky Mountain Laboratories in Hamilton, Montana, he evaluates medical countermeasures against Ebola viruses. Additionally, Dr. Halfmann focuses on understanding the landscape of known and unknown viruses with collaborators in Sierra Leone. Working closely with Waisman Biomanufacturing at UW–Madison, he is progressing his novel whole-virus Ebola vaccine to clinical trials. His research goals are to advance our understanding of viral threats and develop effective countermeasures.